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Summary 
Class I MHC expression by target cells inhibits lysis 
mediated by natural killer (NK) cells, often in an allele- 
specific fashion. It has been proposed that NK cell in- 
hibitory receptors recognize complexes of class I moi- 
ecules with specific cellular psptides that define self, 
displacement of which would render cells NK sensi- 
tive. By loading the mostly empty Dd class I molecules 
of cell lines deficient in peptide transporter molecules 
with synthetic or natural W-bound peptides, we have 
demonstrated specific dose-dependent inhibition of 
the Ly49+ subset of activated NK cells by class I-pep 
tide complexes. Inhibition occurred with most if not 
all Dd-binding peptides, suggesting that Ly49+ NK cells 
recognize class I-psptide complexes largely indepen- 
dently of peptide composition. The results suggest a 
primary role of NK cells in the destruction of ceils that 
have down-regulated or extinguished cell surface ex- 
pression of some or all class I molecules. 
Introduction 
Natural killer (NK) cells lyse transformed, virus-, and intra- 
cellular bacteria-infected cells, mediate potent antibody- 
dependent cellular cytotoxicity (ADCC) (reviewed by Trin- 
chieri, 1989) and are able to mediate rejection of bone 
marrow allografts c/u et al., 1992). The specific receptors 
employed by NK cells for recognition and activation remain 
poorly defined, but they probably include both triggering 
and inhibitory molecules (Correa et al., 1994; Storkus and 
Dawson, 1991). 
Many studies concur that the expression of major histo- 
compatibility complex (MHC) class I molecules on target 
cells has an inhibitory effect on NK cell lytic activity, over- 
ruling triggering signals. Tumor cells or normal lympho- 
blasts deficient in class I expression due to various muta- 
tions are sensitive to NK-mediated lysis, which can be 
inhibited by restoring class I expression (Hoglund et al., 
1991; Liao et al., 1991; Storkus et al., 1989). In vivo, NK 
cells in normal mice mediate rejection of syngeneic class 
l-deficient tumor cells or class l-deficient bone marrow 
cells (Bix et al., 1991; Karre et al., 1988). In systems where 
NK clones or NK subsets have been analyzed, the inhibi- 
tory effect of class I expression has a clear allelic specific- 
ity (Karlhofer et al., 1992; Moretta et al., 1990; Sentman 
et al., 1989). These studies suggest that the population 
of NK cells in normal animals contains several subsets of 
effector cells with distinct, but probably overlapping, class 
l-allele specificities. 
Several models have been considered to explain the 
inhibitory effect of class I molecules on NK activity (Ljung- 
gren and Karre, 1990). Recent evidence supports the re- 
ceptor inhibition model, in which NK cells bear receptors 
that specifically bind class I molecules, transmitting an 
inhibitory signal into the NK cell that prevents target cell 
lysis mediated by other receptor-ligand interactions. The 
first candidate for an inhibitory class l-specific receptor 
on murine NK cells is the Ly49 molecule, expressed by 
150620% of NK cells (Karlhofer et al., 1992). Ly49 is a 
type II integral membrane protein, with an external C-type 
lectin domain, expressed as a disulfide-linked homodimer 
of 44 kDa subunits (Yokoyama and Seaman, 1993). Ex- 
pression of Dd or Dk molecules on susceptible target cells 
renders them resistant to lysis by Ly49+ NK cells, whereas 
H-2b class I molecules are permissive for lysis. Expression 
of Dd or Dk molecules on a target cell globally inhibits Ly49+ 
NK cell activity, preventing ADCC as well as tumor cell 
lysis (Correa et al., 1994; Karlhofer et al., 1992). Direct 
physical interaction between Ly49 and Dd or Dk molecules 
has bsen demonstrated by binding of Ly49+ cells to purified 
Dd or Dk molecules (Kane, 1994) and by binding of Ly49- 
transfected Chinese hamster ovary cells to target cells 
expressing transfected W molecules(Danielset al., 1994). 
In both binding systems, the interaction could be blocked 
with antibodies reactive with the appropriate class I mole- 
cule or with Ly49. It is likely that other related receptors 
with different specificities also exist, given the existence 
of several Ly49-related genes (Smith et al., 1994) and of 
murine NK subsets with distinct class I allele specificities 
(Sentman et al., 1989). Furthermore, several putative 
class l-specific inhibitory receptors have been identified 
on human NK cells with monoclonal antibodies (MAbs) 
(Litwin et al., 1994; Moretta et al., 1993, 1994). 
MHC class I molecules consist of a complex of a poly- 
morphic heavy chain, the noncovalently associated light 
chain j32-microglobulin (f&m), and a short peptide derived 
from a degraded intracellular protein. Since the main func- 
tion of class I molecules is to present antigen-derived pep- 
tides to the immune system, it is important to address 
whether the peptide-binding domains of class I molecules 
are involved in NK recognition and, specifically, whether 
inhibitory receptors on NK cells interact with specific class 
I-peptide complexes. This question is central to under- 
standing the physiological role of class I inhibition of NK 
activity, and, consequently, the role of NK cells in the im- 
mune response. 
A prevalent hypothesis is that a small subset of special- 
ized cellular peptides, presented by class I molecules, 
serves to define cells as normal wRh respect to NK cells, 
thereby inhibiting lysis (Chadwick et al., 1992; Kaufman 
et al., 1992; Storkus et al., 1991). Acute intracellular infec- 
tion, which may flood the cell with new antigenic peptides, 
might displace inhibitory peptides and render the cells NK 
sensitive. Loss of class I molecules from the cell for other 
reasons would also lead to NK sensitivity. A competing 
hypothesis is that NK cells recognize assembled class I 
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Figure 1. Expression of Dd Molecules in RMA- and RMAIS- 
Transfected Cells 
Untransfected and transfected cells were incubated for 21 hr at room 
temperature in 10% FCS and then stained with anti-Db (622-249) or 
anti-Dd (34-2-12s) fluoresceinated antibodies. 
molecules independently of their peptide composition. 
This would suggest that the role of class I inhibition of NK 
cells is in protection against autologous cells that lose 
expression of some or all class I molecules, which could 
allow the cells to escape recognition by cytotoxic T cells. 
Several observations have provided indirect support for 
the role of specific peptides in NK cell inhibition. Exon- 
shuffling experiments indicated a critical role for the pep- 
tide-binding al/a2 domain of the class I molecule in inhibi- 
tion of human NK cells (Storkus et al., 1989). Also, the 
al/a2 domain of Dd has been implicated in mediating inhi- 
bition of Ly49+ NK cells in the murine system (Karlhofer 
et al., 1992; Sykes et al., .1993). Furthermore, an amino 
acid substitution on the al ‘helix that is thought to unblock 
a pocket in the peptide-binding groove converted the HLA- 
A2 molecule from a silent class I molecule into an inhibitory 
one(Storkuset al., 1991). Anothertypeof studyhasshown 
that incubation of normal target cells with specific class 
l-binding peptides can, in some cases, render the cells NK 
sensitive; it was suggested that the exogenous peptides 
displaced specific endogenous inhibitory peptides (Chad- 
wick et al., 1992; Storkus et al., 1992). However, none 
of these studies provided direct evidence that a special 
subset of peptides or, for that matter, any peptides, are 
involved in class I inhibition of NK activity. 
To address this important issue, we have employed cell 
lines deficient in the expression of transporters associated 
with antigen processing (TAP molecules), responsible for 
importing peptides from the cytoplasm to the endoplasmic 
reticulum, where they associate with class I molecules. 
Peptide inavailability due to TAP deficiency results in inef- 
ficient class I assembly and transport to the cell surface. 
Some class I molecules reach the cell surface, but these 
are mostly “empty” of peptides, and are, therefore, highly 
unstable at 37°C. However, class I molecules on TAP- 
deficient cells can be very efficiently loaded with exoge- 
nous peptides, stabilizing the molecules, and leading to 
a strong increase in the level of properly folded class I 
complexes on the cell surface (Ljunggren et al., 1990; 
Rock et al., 1991). 
Normal and transformed TAP-deficient cells are sensi- 
tive to NK lysis when compared with wild-type cells 
(Franksson et al., 1993; Ljunggren et al., 1994). It was not 
established whether the NK sensitivity is due to low class 
I expression, to the lack of TAP-dependent peptides in 
general, or to the lack of a specific subset of TAP-dependent 
peptides. In this report, we have employed class I transfec- 
tants of the TAP-deficient cell line RMA/S, loaded under 
defined conditions with various synthetic or natural pep- 
tides, to examine the role of class l-bound peptides in 
recognition by Ly49+ NK cells. The results demonstrate 
for the first time that class I-peptide complexes cause 
inhibition of NK activity. It appears, however, that many, 
if not all, class l-binding peptides cause inhibition. We 
propose that NK cells recognize properly folded class I 
complexes largely independently of the peptide compo- 
sition. 
Results 
Expression of Dd Molecules on TAPBDeficient Ceils 
To generate TAPdeficient cells expressing the Dd mole- 
cule, the TAPedeficient cell line RMA/S (H-p), as well as 
wild-type RMA cells, were transfected with the Dd gene. 
The cell surface levels of Dd were monitored with the a3 
domain-specific MAb 34-2-12s (Evans et al., 1982). 
Transfected RMA/S clones were obtained with 5%-59% 
the Dd level of wild-type RMA. Dd cells, as determined after 
overnight preculture at room temperature in 10% fetal calf 
serum (FCS). One of the clones with the highest level of 
Dd was used in these experiments. The wild-type and TAP- 
deficient Dd-transfectants selected for further studies were 
denoted RMA.Dd and RMAIS.Dd, respectively (Figure 1). 
Further analysis of Dd expression employed the MAb 
345-8s, which binds a conformation-sensitive epitope 
present in the peptide-binding region of the Dd molecule 
(Evans et al., 1982; Otten et al., 1992). The Dd level on 
wildtype RMA.Dd cells was similar to Dd levels on the P815 
mastocytoma or the A20 B lymphoma, and somewhat 
higher than on a IY transfectant of the R8.15 cell line pro- 
vided by Dr. T. Potter (Table 1, experiment 1). Dd stabiliza- 
tion on RMA/S.Dd cells was generally greater at room tem- 
perature than at 37°C as found for other class I molecules 
on TAP-deficient cells. Exogenous bovine or human Pnrn 
(h&m) resulted in increased Dd stabilization at both tem- 
peratures, but more markedly at room temperature. The 
Dd-specific peptide pHlV (see Table 2 for a description of 
peptides employed in this study) stabilized Dd molecules 
at both temperatures. The addition of both peptide and 
hp,m at 37OC caused the highest level of Dd expression at 
the ceil surface. The peptide-associated molecules were 
functional, as they were able to stimulate an HIV-peptide/ 
Dd-specific T cell hybridoma (data not shown). 
Little or No Inhibition of Lysis by RMA/S.Dd Cells 
Previous studies showed that the lysis of susceptible tu- 
mor cell lines by Ly49+ adherent lymphokine-activated 
killer (AUK) cells was inhibited when the cells were 
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Table 1. Dd Expression in Transfected Cells and Stabilization of Dd Molecules on 7ap2-Deficient Cells 
Cell Line 
Overnight Incubation in the Presence of Mean of Fluorescence Intensity 
10% FCS 0.2% FCS hP2ma pHIVb No Antibody Da (34-5-8s) 
Experiment 1 
37oc 
RMA.D4 
A20 
P815 
R8.15.Dd 
RMAIS.Da 
Experiment 2 
37oc 
RMAJY 
RMAIS.Da 
RT” 
RMAIS.DO 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
- 2 76 
- - 2 96 
4 75 
2 39 
2 32 
- 5 210 
- - 3 30 
- - + 3 181 
+ 2 6 
+ + - 2 86 
+ + 3 296 
+ + + 3 420 
+ 3 87 
+ - - + 3 305 
+ 3 18 
+ + 3 142 
+ - + 3 320 
- + + + 3 334 
e hft2rn at 2.5 &ml 
b pHlV peptide at 10e5 M 
c RT, room temperature 
transfected with the Dd gene (Karlhofer et al., 1992). For 
example, the R8.15 cell line, an H@ loss variant of an 
H-2Wd cell line (Connolly et al., 1988) was lysed efficiently 
by Ly49’ AUK cells, whereas the Dd-transfected R8.15 
line (R8.15.Dd) was not lysed (Figure 2A; Correa et al., 
1994). In contrast, expression of Dd in TAPa-deficient 
RMA/S.Dd cells caused essentially no inhibition in most 
(19 of 23) experiments (Figures 2B and 2C), or substan- 
tiallylessinhibition than wasobserved in the caseof R8.15 
cells (Figure 2A, depicting the largest inhibition observed). 
Dd expression in the TAPBdeficient cells had little effect 
in most experiments regardless of the availability of exoge- 
nous Prim, as shown by the data in Figures 2A and 28 with 
bovine Bprn (contained in 10% FCS), or Figure 2C with 
limiting amounts of bovine L&m (0.2% FCS) with or without 
addition of 2.5 uglml hP2m. Preculturing the cells at room 
temperature (Figures 2A and 28) or at 37°C (Figure 2C) 
did not affect the results. The level of Dd on RMA/S.Dd 
cells cultured overnight at room temperature was actually 
higher than on R8.15.Dd cells at the initiation of the cyto- 
lytic assay and after 1.5 hr at 37°C (legend to Figure 2). 
However, the levels fall sharply after 2 hr at 37OC (data 
not shown). These results suggest that the ‘empv Dd mole- 
culeson TAP-deficient cells are, at best, inefficient at inhib- 
iting Ly49+ A-LAK activity, either because these molecules 
are not recognized well by Ly49+ effector cells, or because 
the levels of these molecules are too low to cause inhibition 
after incubation at 37OC. 
Table 2. Da and H-p-Specific Peptides 
Amino Acid Position 
Peptide 1 2 3 4 5 6 7 8 9 10 11 Reference 
Da specific 
pHlV 
pD36 
pD38A 
pD39 
pD44 
pTum- 
Db specific 
PNP 
Kb specific 
pOVA 
R G P G R A F V T I 
V 0 P 0 K N E N L 
A G P D R T E K L 
K G P D K G N E F 
D G P V R G I S I 
G P P H S N N F G Y’ 
A S N E N M E T M 
S I I N F E K L 
(Shirai et al., 1992) 
(Corr et al., 1993) 
(Corr et al., 1993) 
(Corr et al., 1993) 
(Corr et al., 1993) 
(Szikora et al., 1990) 
(Townsend et al., 1986) 
(Carbone and Bevan, 1989) 
* Aligned with the motif (typed in bold) defined by Corr et al. (1993). 
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Fiie 2. Inefficient or No Inhibition of Ly4C A-LAK Cells by TAPP- 
Deficient Target Ceits 
Target cells were incubated overnight at room temperature (A and B) 
or at 37OC (C) with ihe indiited additions, labeled with Wr for 1 hr 
at the same temperature as the overnight incubation, and assayed 
for sensiUvity to lysis by Ly49+ A-lAK cells. 
(A and B) Cells were preincubated in 10% FCS. In the experiment in 
(A), expression of Dd molecules was analyzed with the anti-W (al/a2 
domains) antibody (34-5-5s). Means of fluorescence intensity (MFI) 
were the following: R&15, 6; WA/S, 20; RMA/S.Dd, 112; RB.15.Dd, 
47. The MFI on RMA/S.Dd cells was 90 after 1.5 hr at 37W. 
(C)Cells were preincubated in 0.2% FCS in the absence or the pres- 
ence of 2.5 @ml of h&m. Expression of Dd molecules was analyzed 
with the anti-D’ (a3 domain) MAb (34-2-12s). MFI were the following: 
RMAIS. 3; RMA/S.D. 32; and RMAIS.Dd plus hb2m, 50. 
Role of D%pecitic Peptldes in inhibiting the Lysis 
ot RMA/s.w Colts 
To study the effect of peptides bound to class I molecules 
on tysis of tumor cells by Ly49+ A-LAK cells, class I mole- 
cules on RMAE3.W cells were loaded with various syn- 
thetic peptides (see Tabie 2), and the cells were tested 
for sensitivity to lysis by Ly49+ A-LAK cells (Figure 3A). In 
this and eight other experiments, incubation of RMA/S.Dd 
celts with a W-binding peptide (pD44) resulted in strongly 
reduced lysis, compared with incubation with no peptide. 
Incubation with a Db-binding peptide (pNP) did not signifi- 
cantly affect lysis by Ly49+A-LAK cells(Figure 3A), though 
it dii strongly increase the expression of Db at the cell 
surface (legend to Figure 3). In parallel with the induction 
of resistance to lysis, preincubation with the pD44 peptide 
strongly stabilized Dd molecules on the cell surface, 
whereas preincubation with the pNP peptide had no effect 
on Dd levels (inset of Figure 3). The effects of pD44 were 
largely dependent on the Dd molecule, because the lysis 
of untransfected RMA/S cells was only slightly affected 
by incubation with the pD44 peptide. The pD44 peptide 
did not affect susceptibility of the target cells to lysis by 
all NK cells, as shown by the minimal effect of the peptide 
on lysis of RMA/S.Dd cells by Ly49- AUK cells (Figure 3s). 
The dose-response curves of pD44 and several other 
peptides (see Table 2) in inhibiting lysis of RMA/S.Dd cells 
by Ly49+ A-LAK cells were compared (Figure 3C). Of 6 
peptides tested, 5 strongly inhibited lysis in a similar dose- 
dependent manner, with half-maximal inhibition occurring 
at concentrations near 10” M. One peptide (pTum-) inhib- 
ited lysis poorly, exhibiting weak inhibition only at much 
higher concentrations (Figure 3C). 
The five peptides that strongly inhibited lysis were all 
potent at stabilizing Dd molecules on the cell surface, ex- 
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Figure 3. DWpecific Peptides Inhibit the Direct Lysis of RMA/S.Dd 
Cells by Ly49+ A-LAK Cells 
(A and B) Cells were incubated with peptides (5 x IO-’ M) in the 
presence of 1 @ml of h&m overnight at 37OC, and tested for lysis 
by NK cells or Dd stabilization (inset). Ly49+ (A) and Ly49- (8) effector 
cells were compared. The pNP peptide shifted the MFI of Db staining 
from 27 to 154, compared with an MFI of 250 for wild-type cells, as 
determined with 822-249 antibody. 
(C and D) RMA6.D cells were incubated with graded concentrations 
of six W-specific peptides. Labeled cells were used as target cells for 
Ly49+A-lAKcells at aneffectorto target ratioof3O:l (C). Aliquotsofthe 
peptide-incubated cells were employed to determine Dd stabilization 
levels (D). 
hibiting a dose-response relationship similar to that of inhi- 
bition (Figure 3D). pTum- was the least potent peptide in 
the W stabilization assay, correlating with its poor activity 
in inhibiting lysis mediated by Ly49+ effector cells (see 
Discussion). Thus, assembly of an inhibitory peptide-Dd 
complex can occur with each of several randomly chosen 
Dd-binding peptides, and the level of inhibition correlates, 
at least roughly, with the level of stabilized peptide-Dd 
complexes on the cell surface. 
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Figure 4. Effect of Dd-Specific Peptides on ADCCMediated Lysis of 
RMA/S.Dd Cells by Ly49+ AUK Cells 
(A and 6) RMA/S.Dd cells incubated with peptides, or not, were com- 
pared for sensitivity in assays of direct lysis (A) or ADCC (B). 
(C) The Dd stabilization levels resulting from incubation with the pep- 
tides were determined in parallel with an aliquot of the cells. The cells 
were incubated with pD44 alone (4 x 10d M), or a mixture of four 
W-binding peptides (pD96, pD66, pDS9, and pD44, at IO+ M each, 
denoted Mix), at 37OC for 12 hr in 0.2% FCS supplemented with 1 
ug/ml hg,m. Controls included RMA/S cells incubated with the peptide 
mix. In the ADCC experiment, strong inhibition by control RMA.W 
cells, in comparison to RMA cells, is evident. 
Incomplete Inhibition Mediated by Peptide-Loaded 
Dd Molecules on TAPZ-Deficient Dells 
Although the peptide-loaded Dd molecules on RMA/S.Dd 
cells inhibited lysis reproducibly, the percentage of inhibi- 
tion was consistently less than the percentage of inhibition 
caused by Dd molecules on wild-type cells (e.g., Figure 
2A), despite the fact that Dd levels on the former cells 
were often higher than the levels on the wild-type cells. 
A possible explanation was that the simultaneous binding 
of several peptides to the cell would cause additive or 
synergistic inhibition. However, a mixture of four Dd- 
binding peptides caused no greater inhibition than the 
pD44 peptide by itself (Figure 4A). Another possibility was 
that greater inhibition would occur when Dd and non-Dd 
class I molecules on the ceils were simultaneously loaded 
with peptides. However, we observed that a mixture con- 
taining a Kb-binding peptide, a Db-binding peptide, and four 
Dd-binding peptides, each at relatively high concentration, 
was no more effective at inducing inhibition than was a 
single Dd-binding peptide (data not shown). 
In a previous study (Correa et al., 1994), we showed that 
Dd-transfected cells inhibited ADCC mediated by Ly49+ 
AUK cells relatively inefficiently. Hence, ADCC was em- 
ployed here as a stringent assay for class l-mediated inhi- 
bition. Incubation of RMA/S.Dd cells with a single Dd- 
binding peptide, or with a mixture of Dd-binding peptides, 
inhibited ADCC only modestly, by approximately67% (i.e., 
three timesmoreeffectorswererequiredforthesamelevel 
of lysis) (Figure 48). Although the inhibition was weak, it 
was specific for Dd-transfected cells incubated with Dd- 
binding peptides (Figure 4B), and was reproduced in each 
of seven experiments. In contrast, Dd expression by wild- 
type RMA cells resulted in much stronger (96%) inhibition 
of ADCC mediated by Ly49+ effector cells (Figure 48). This 
effect was despite the fact that the level of Dd molecules 
detected with the 34-5-6s MAb was actually lower on the 
RMA.Dd cells than on the peptide-loaded RMA/S.Dd cells 
~~~~~~ 
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Figure 5. Similar Inhibition by Natural Peptides Eluted from Dd Mote- 
cules and Synthetic Dd-Binding Peptides 
(A) Direct lysis by Ly49+ A-LAK cells of RMA/S.Dd cells coated with 
natural peptides at 37OC for 16 hr in 0.2% FCS plus 2 pg!ml h&m. 
Peptides eluted from Dd Or Db molecules immunopurified from 6 x 
10 RMA. Dd cells (or 1110 that amount) were employed as indicated. 
(B and C) A separate experiment in which RMA/S.W cells were coated 
with graded doses of natural peptides or a pool of synthetic peptides 
at room temperature for 15 hr in 0.2% FCS. These cellswereempfoyed 
as target cells for Ly49+ A-LAK cells at an effector to target ratio of 
SO (B), or examined for W stabilization levels (MFI of unstained cells 
was 0.2) (C). The MFI values were lower than seen in previous experi- 
ments due to the use of an EPICS XL instead of a FACScan. The 
mixture of synthetic peptides included pD66. pD66, pD39, and pD44. 
The concentration scale on the abscissa of (B) and (C) refers to the 
total concentration of synthetic or natural peptides. 
(Figure 4C). These results suggested that loading Dd mole- 
cules on TAPPdeficient cells with these synthetic peptides 
does not completely restore the inhibitory phenotype of 
the cells to wild-type levels. We therefore considered the 
possibility that specific natural peptides, bound to Dd mole- 
cules on normal cells, result in more potent inhibition of 
lysis. 
Effecte of Natural W-Specific Peptides 
in NK Cell Inhibition 
Complex peptide mixtures eluted from class I molecules 
of relatively small numbers of normal cells and containing 
tiny amounts of T cell epitopes confer sensitivity of target 
cells to cytotoxic T cells (CTL) (Rammensee et al., 1993). 
If highly potent specialized NK-inhibitory peptides are 
present on Dd molecules on normal cells at similarly low 
levels, it should be possible to transfer resistance to RMAl 
S.Dd cells by preincubating them with relatively few cell 
equivalents of peptides eluted from Dd molecules on nor- 
mal cells. 
To test this possibility, peptides were eluted from Dd 
molecules that had been immunopurified from wild-type 
RMA.Dd cells. Because RMA.Dd cells inhibited ADCC in 
comparison to untransfected RMA cells (Figure 4B), they 
represented an appropriate source of potentially inhibitory 
peptides. The natural Dd peptide mixture, when added to 
RMA/S.Dd cells, caused modest inhibition of direct lysis 
mediated by Ly49+ A-LAK cells (Figures 5A and 5B), and 
modestly increased the level of cell surface Dd expression 
(Figure 5C). The concentrations of the natural peptide mix- 
ture required to observe both effects were similar to the 
concentrations of synthetic peptides required to observe 
these effects (Figures 58 and 5C). Control peptides eluted 
from Db molecules were at least 1 O-fold less potent in inhib- 
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Table 3. Effect of Natural Peptides from Acid Extract of RMA.Dd 
Cells on Lysis of RMA/S.Dd Cells by Ly49’ A-LAK Cells 
Peptide 
MFI of 
Percent of Specific Lysis 
RMAIS.Dd RMA/S.Dd RMAIS 
None 
Synthetic mix 
6 x 10-eM 
6 x IO-‘M 
6 x 10.‘M 
6 x lO+M 
Acid extract from 
RMA.Dd cells 
(dilution) 
1’ 
t/4 
1116 
1164 
5.3 
16.4 19/l 3/t 1 39134127 
16.3 23117114 42i35i26 
15.4 31/23/17 40135129 
6.9 39126123 40136126 
27.9 20/17/14 39132i27 
16.7 31/22/16 44134126 
6.1 35130124 40131127 
5.9 39135127 4 1126132 
39/34/27 49140133 
RMAIS.Dd cells (1.5 x IO8 cells/ml) were incubated for 14 hr at 37OC 
in 0.2% FCS-RPM1 containing 2 pglml of hp,m, with graded amounts 
of a mixture of synthetic peptides (pNP, pOVA, pD36, pD36, pD39, 
pD44) or Cfold dilutions of peptides from acid treatment of RMA.Dd 
cells. One half of the cells were stained with the anti-Dd antibody 34-5 
6s to detect stabilization of Dd molecules on the cell surface (MFI of 
unstained cells was 0.2). The other half of the cells was labeled with 
“Cr and used as targets for Ly49+ A-LAK cells. Results from three 
effectorkarget ratios (30/15/7.5) are shown for each sample. 
l The starting amount was l/3 of the total material obtained from 
6.5 x lb cells. 
iting lysis (Figure 5B). There was no indication that the 
natural Dd peptide mixture was more potent than the mix- 
ture of synthetic peptides tested in parallel (Figures 5B and 
5C). In accord with this conclusion, the eluted Dd peptides 
resulted in only very weak inhibition of ADCC of RMA/S.Dd 
cells mediated by Ly49+ A-LAK cells (data not shown). 
Reverse phase high pressure liquid chromatography 
(RP-HPLC) fractionation of the peptides eluted from Dd mot- 
ecules isolated from 1 x 1 010 RMA.Dd cells was performed 
to determine whether inhibition was mediated by a specific 
peptide in the mixture. The results revealed weak inhibi- 
tion by each of the fractions across the region of the elution 
gradient that contained peptides capable of stabilizing Dd 
expression (data not shown). The weak inhibition was com- 
mensurate with the level of inhibition caused by compara- 
ble concentrations (as determined by levels of Dd stabiliza- 
tion) of synthetic peptides titrated in the same assay. Most 
importantly, no specific peak of inhibitory activity was ob- 
served among the fractions. Thus, there was no indication 
that the eluted Dd peptide preparation contains specific 
highly potent inhibitory peptides. Rather, the mixture ap- 
pears to contain many inhibitory peptides with similar po- 
tencies to the synthetic peptides we tested. 
The possibility remained that there exists a specific set 
of natural peptides that strongly inhibit NK lysis, which 
bind Dd loosely and were, therefore, selectively lost during 
the immunopurification of Dd molecules. To examine this 
possibility, we acid-extracted peptides directly from live 
intact RMA.Dd cells, as has been recently reported for T 
cell epitopes (Storkus et al., 1993). Brief acid treatment 
was apparently sufficient to remove the relevant Dd- 
binding peptides from the cells, because the treated cells 
were considerably more sensitive to ADCC mediated by 
Ly49+ AUK cells than were untreated cells; ADCC by 
Ly49- AUK cells was much less affected (data not 
shown). When RMA/S.Dd cells were exposed to concen- 
trated samples of the supernatant peptides, increased Dd 
stabilization was noted, and the cells were rendered par- 
tially resistant to lysis mediated by Ly49+ AUK cells (Ta- 
ble 3). Compared with a mixture of synthetic peptides ana- 
lyzed in parallel, the level of inhibition was commensurate 
with the level of Dd stabilization. Lysis of RMA/S cells was 
unaltered by incubation with this material. Hence, the acid 
extracts contained specific inhibitory peptides, but the po- 
tency of this peptide mixture was no greater than the po- 
tency of the synthetic peptides previously analyzed. These 
results, like those earlier, provide no evidence for a spe- 
cific subset of natural peptides that are highly potent in 
causing inhibition of NK lysis. 
Discussion 
Inhibition of NK Activity by Exogenously Loaded 
Peptides on Class I Molecules 
of TAP-Deficient Cells 
The results presented ‘herein demonstrate that Dd mole- 
cules expressed by TAP-deficient cells only occasionally 
inhibited lysis mediated by Ly49+ AUK cells, whereas 
peptide-loaded Dd molecules on TAP-deficient cells 
caused consistent and substantial inhibition. In the few 
cases where inhibition by unloaded TAP-deficient cells 
was apparent (e.g., Figure 2A), it is unclear whether it was 
mediated by empty Dd molecules, which are prevalent on 
TAP-deficient cells, or by a subset of peptide-loaded Dd 
molecules on the TAP-deficient cells. It has been shown 
that alternative pathways operative in TAP-deficient cells 
can provide peptides that bind some class I molecules 
(Wei and Cresswell, 1992). 
The most significant observation in this study was that 
5 of the 6 randomly chosen Dd-binding peptides caused 
clearcut and substantial inhibition of lysis of RMA/S.Dd 
cells mediated by Ly49+ effector cells. Of these 5 peptides, 
1 corresponded to an HIV T cell epitope, and the remaining 
4 corresponded to peptides found at relatively high levels 
on normal H-2d cells. An exceptional peptide was pTum-, 
which caused only weak inhibition, but also bound rela- 
tively weakly to Dd molecules, as shown in the Dd stabiliza- 
tion assay. We have recently tested a panel of 11 addi- 
tional peptides that contained the Dd-binding peptide motif, 
but random residues at the nonanchor positions (I. C., J. 
Zerrahn, and D. H. R., unpublished data). Each of these 
peptides also caused inhibition of Ly49+ effector cells, with 
the extent of inhibition roughly commensurate with the 
level of binding of the peptides to Dd molecules. Our results 
represent the first direct evidence that class I-peptide 
complexes induce inhibition of NK cells, at least in the 
case of the Ly49+ subset. Equally significant, and contrary 
to expectations, the results suggest that the inhibition is 
not dependent on a specific set of autologous peptides 
expressed by normal cells. The present experiments are 
an improvement over the earlier studies on this question, 
$ass I-Bound Peptides Inhibit NK Cells 
because the effects of peptides were assessed directly 
rather than indirectly, and an NK subset of defined speci- 
ficity, rather than bulk NK cells, was employed. Further 
experiments will be necessary to establish whether Ly49- 
NK cell subsets exhibit a similar promiscuity with respect 
to the class ITbound peptides that cause inhibition. 
The poor activity of the pTum-.peptide in the lysis inhibi- 
tion and Dd stabilization assays may be related to the fact 
that the lo-mer we employed extends an extra two amino 
acids at the C terminus when aligned with the recently 
defined Dd motif (see Table 2); previous studies demon- 
strated that the C-terminal dipeptide decreases the capac- 
ity of this peptide to stabilize Dd molecules (Corr et al., 
1993). However, poor binding of the peptide may not com- 
pletely account for its poor inhibitory activity, because in 
several experiments it appeared that doses of pTum- suffi- 
cient to cause significant stabilization of Dd, caused less 
inhibition than would be expected based on the behavior 
of the other peptides. For example, in the experiment pre- 
sented in Figure 3,5 x lo-’ M pTum- stabilized Dd to the 
same extent as 2.5 x 10” M of three of the other peptides, 
yet caused significantly less inhibition. Although the dis- 
crepancy in this case was not dramatic, it is possible that 
some peptides cause relatively poor inhibition yet bind 
reasonably well. Perhaps the side groups of such peptides 
impede the inhibitory receptor of the NK cell, or alter the 
conformation of the region of the Dd molecule recognized 
by the inhibitory receptor. Isolation and characterization 
of additional peptides that cause relatively poor inhibition 
may help to provide significant insights into the way in 
which Ly49 interacts with the Dd molecule. 
In the case of peptides corresponding to CTL epitopes, 
extremely low peptide doses, often as low as 10-l’ M, are 
typically required to render normal or TAP-deficient target 
cells sensitive to specific CTL. Based on these observa- 
tions, it has been estimated that as few as 100 specific 
class I-peptide complexes per cell are suff icient to activate 
CTL (Christinck et al., 1991). In contrast, the doses of 
synthetic or natural peptides required for inhibition of 
Ly49+ A-LAK cells were relatively high, near the doses 
required to observe increased staining of Dd on the cells. 
This observation would suggest that inhibition of Ly49’ 
NK activity requires a much larger number of peptide-Dd 
complexes than activation of CTL. Perhaps signal trans- 
duction through Ly49 requires more extensive cross- 
linking than signal transduction by the T cell receptor; 
alternatively, the affinity of Ly49 for class I-peptide com- 
plexes may be lower than the typical affinity of T cell re- 
ceptors. 
A recent paper proposed that NK cells are inhibited by 
free class I heavy chain on target cells, rather than by 
assembled class I molecules (Carbone et al., 1993). This 
hypothesis was based on findings that the addition of exog- 
enous 8?rn to TAP-deficient human target cells, and, to a 
lesser extent, to normal human target cells, increased the 
level of NK-mediated lysis of these cells. The addition of 
finm favors class I+rn assembly and should reduce the 
level of free class I heavy chains on the cell surface. In 
contrast, in our experiments, exogenous Pnrn did not en- 
hance the sensitivity of TAP-deficient target cells (Figure 
2C) or normal target cells (data not shown) to lysis by NK 
cells. Our results in the Ly49 system are consistent with 
inhibition mediated by class I-peptide complexes, and not 
by free class I heavy chains. 
No Evidence for Specialized NK-Inhibitory 
Natural Peptldea 
Although our data suggest that most Dd-binding peptides 
cause inhibition of Ly49+A-LAK cells, it remained possible 
that there exists a subset of natural peptides that are much 
more potent than the synthetic peptides employed here. 
Experiments designed to detect such peptides on normal 
cells were uniformly negative. Natural peptides eluted 
from Dd molecules caused inhibition, but no more so than 
similar doses of synthetic peptides. Furthermore, RP- 
HPLC analysis revealed a broad distribution of inhibitory 
peptides, and no potent specific peptides. We had rea- 
soned that fractionating the peptides by RP-HPLC might 
reveal potent inhibitory peptides by reducing the number 
of competing less inhibitory peptides in each fraction. Fi- 
nally, the peptide mixture extracted from live cells by brief 
acid treatment also exhibited a similar dose-response 
curve to that of the synthetic peptides. Our results provide 
no evidence for specificity among natural peptides in their 
capacity to inhibit Ly49+ NK cells. Therefore, we favor the 
interpretation that inhibition is a consequence of the con- 
certed action of most of the class I-peptide complexes 
found on normal cells, rather than of a specialized subset 
of them. However, we cannot formally exclude the exis- 
tence of a more potent subset of inhibitory peptides that 
escaped our detection methods. One possibility is that 
such peptides may not compete well with irrelevant pep- 
tides for Dd binding, even after HPLC fractionation. 
Taken together with earlier findings, an implication of 
our results is that the NK receptors, at least the Ly49 recep- 
tor, recognize conformations of the peptide-binding do- 
main that may be peptide dependent but are not peptide 
specific. This recognition pattern is in contrast not only 
with antigen-MHC-specific T cell receptors, but also to 
typical allospecific T cell receptors, most of which are pep- 
tide specific (Heath et al., 1991). However, some allospe- 
cific T cell receptors may be relatively peptide nonspecific 
(Bluestone et al., 1993), suggesting the possibility that 
these T cell receptors and the Ly49 receptor family may 
recognize similar conformational features of class I mole- 
cules. The NK recognition studied here might also be con- 
sidered allospecific, because the effector cells were de- 
rived from H-2b mice and inhibition was mediated by Dd. 
However, Ly49+ AUK cells derived from H-2d (BlO.D2) 
mice were shown to be inhibited by RMA/S.Dd cells loaded 
with each of the three peptides we tested (pD36, pD38A, 
and pD39) (I. C. and D. H. R., data not shown), suggesting 
that these effecters are also inhibited by diverse Dd-binding 
peptides. 
The previous evidence invoked to suggest a role for 
specialized peptides in the NK inhibitory pathway included 
the effects of an amino acid substitution in the al helix 
of the HLA-A2 molecule, which resulted in strong resis- 
tance of transfected target cells to NK-mediated lysis 
(Storkus et al., 1991). This substitution is thought to affect 
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peptide binding, but it may also affect the direct interaction 
of the molecule with the inhibitory receptor on NK cells, 
or it may alter the conformation of the molecule in a way 
that affects interaction with the inhibitory receptor. 
More difficult to understand are the effects of exogenous 
addition of class l-binding peptides to normal target cells, 
which reportedly increased their sensitivity to lysis (Chad- 
wick and Miller, 1992; Storkus et al., 1992). It was sug- 
gested that the exogenously added peptides displaced 
specialized class l-bound peptides, relieving the inhibition 
of NK cell activity. It is somewhat difficult to envision how 
natural class l-bound peptides, which generally have slow 
dissociation rates (Cerundolo et al., 1991), could be so 
efficiently displaced by the addition of exogenous pep- 
tides. Furthermore, in most cases where we have added 
high concentrations of w-binding peptides to normal cells 
in attempts to confirm this phenomenon with Ly49’ ef- 
fector cells, we have observed an increased rather than 
decreased resistance to lysis, or no effect at all (data not 
shown). The basis of the effects of peptide addition to 
normal cells observed in other systems remains unclear. 
Thus, at least in the case of the interaction between 
Ly49+ NK cells and Dd-bearing cells, our results represent 
a strong argument against the peptidedisplacement 
model. Instead, our results are most consistent with the 
conclusion that the main function of the inhibitory NK re- 
ceptors is to engender lysis of cells that lose expression 
of specific class I molecules from the cell surface. Tumor 
cells often lose class I expression owing to mutation or 
as a result of oncogene expression, and the repression 
of class I expression by various viral infections is well docu- 
mented (Ljunggren and Karre, 1990; Maudsley and 
Pound, 1991). The inhibitory specificity of some NK cells 
for particular MHC alleles, rather than for a monomorphic 
determinant on class I molecules, presumably allows the 
detection of target cells in which the expression of one or a 
subset of class I molecules is extinguished. Nevertheless, 
there are reports in which cellular infection resulted in in- 
creased sensitivity to NK cells but did not detectably affect 
class I expression (Kaufman et al., 1992; Malnati et al., 
1993). Perhaps, in those cases, infection augmented tar- 
get cell molecules that activate NK cell lysis. 
incomplete Inhibition of NK Activity by 
Peptide-Loaded TAP-Deficient Cells 
Although the loading of exogenous peptides onto the Dd 
molecules of RMA/S.Dd cells caused substantial and re- 
producible inhibition of specific NK lysis, there were vari- 
ous indications that the inhibition was weaker than that 
accomplished by class I molecules on wild-type cells. Inhi- 
bition of direct lysis was incomplete, and the inhibition of 
ADCC, though reproducible, was quite weak. The weaker 
inhibition was despite the fact that the levels of Dd expres- 
sion were often as high or even higher on the peptide- 
loaded RMA/S.Dd cells than on the wild-type cells used for 
comparison. Loading the cells concurrently with multiple 
Dd-binding peptides, Db- and Kb-binding peptides had no 
more effect than the loading of Dd alone. The possibility 
that complexes formed between Dd and hp,m are less effi- 
cient at causing inhibition of mouse NK cells than com- 
plexes formed with mouse Brim was also considered. How- 
ever, we found that peptide addition in the presence of a 
limiting concentration of FCS (0.2%), conditions where 
most of the complexes are expected to contain mouse 
j3*m, also caused substantial but incomplete inhibition 
(data not shown). 
The basis of the incomplete inhibition is, therefore, un- 
clear. Perhaps the Dd molecules on TAPdeficient cells 
are altered such that they interact poorly with the Ly49 
receptor. For example, alterations of the composition of 
glycans attached to cell surface class I molecules on TAP- 
deficient cells might affect binding of Ly49, which contains 
a putative lectin domain. Alternatively, some other TAP- 
dependent molecules, distinct from Dd, Kb, and Db, may 
participate in the inhibitory pathway. Also, RMA/S.Dd cells 
may be more susceptible to NK-mediated lysis than 
RMA.Dd cells due to alterations in a pathway distinct from 
the class I inhibitory pathway. Finally, as noted above, the 
existence of specialized highly inhibitory class l-bound 
peptides or other ligands cannot be formally excluded. 
A final point that is in need of discussion concerns our 
observation (Correaet al., 1994; data not shown) that RMA 
cells are insensitive to direct lysis by Ly49+ (or Ly49-) 
AUK cells, although these cells are sensitive to ADCC 
mediated by A-LAK cells (Figure 4). This unexpected in- 
sensitivity of RMA cells to direct lysis by A-LAK cells is 
shared by at least two other H-2” cell lines. In principle, 
the failure of the RMA cells to be lysed could be due to 
their inability to activate lysis, or because the cells inhibit 
lysis. We favor the first possibility, because acid treatment 
of cells, which displaces peptides from class I molecules 
on the cell surface, failed to render RMA cells sensitive 
to lysis by Ly49+ AUK cells (data not shown). The same 
treatment specifically increased the sensitivity of RMA.Dd 
cells to ADCC mediated by Ly49+ AUK cells. We suspect 
that RMA/S cells but not RMA cells are able to activate 
A-LAK cells directly, possibly owing to clonal variation in 
expression of relevant activating molecules. A precedent 
is our previous observation that one subline of the EL-4 
cell line, also H-2b, was sensitive to lysis by AUK cells, 
while another EL4 subline was not (Correa et al., 1994). 
These observations are consistent with the idea that the 
outcome of the NK-target cell interaction depends on the 
interplay of activating and inhibitory signals. 
Experimental Procedures 
Mice and Tumor Cells 
C57BU6J (66, H-29 mice were purchased from The Jackson Labora- 
tories (Bar Harbor, Maine). Wild-type RMA and TAP2 mutant RMAIS 
cells (Karre et al., 1966; Yang et al.. 1992) were provided by Dr. M. 
Bevan (University of Washington, Seattle, Washington). R6.15 and 
transfected A6.15.Dd cells (Connolly et al., 1966) were provided by 
Dr. T. Potter (National Jewish Hospital, Denver, Colorado). 
Antibodies 
The mouse anti-p hybridomas 34-2-12s and 34-5-6s (Ozato et al., 
1962) and the mouse anti-Db hybridoma 26-14-6s (Ozato and Sachs, 
1961) were obtained from American Type Culture Collection, and the 
antibodies were purified using protein A-Sepharose. Rat immunoglob- 
ulin G2b (IgGPb) anti-mouse Thy-l .2 MAb (30H12) was purchased 
from Pharmingen (San Diego, California). Polyclonal mouse IgG was 
purchased from Caltag Laboratories(South San Francisco, California). 
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Anti-Ly49 (Al; Nagasawa et al., 1967) and anti-Db (822-249; Lemke 
et al., 1979) antibodies were purified using protein A-Bepharose. 
Preparation of A-LAK Cells 
A-LAK cells are activated NK effector cells. They were prepared by 
culturing spleen cells from B6 mice in the presence of a high concentra- 
tion of interleukin-2 (IL-2), recovering the adherent cells, and recultur- 
ing these cells in IL-2 for several days. They were prepared and sepa- 
rated as previously described (Correa et al., 1994; Karlhofer 81 al., 
1992). Ly49+ and Ly49- populations were separated after 6 days of 
culture by “panning” the cells on antibody-coated petri dishes; the cells 
were washed and returned to culture for 2-3 additional days, during 
which detectable anti-Ly49 antibody was lost from the cells. Routinely, 
the Ly49+ population was greater than 95% pure, the Ly49- population 
contained less than 2% Ly49+ cells, and both populations contained 
greater than 96% NKl .I+ cells. 
Trsnsfeotlon of RMA and WA/S Cells with Dd Gene 
RMA and RMA/S cells were transfected by electroporation (Attaya et 
al., 1992) with pDdl containing the Dd gene driven by its own promoter 
(Evans et al., 1962), cotransfecled with the neoR plasmid pMC1 Neo- 
Poly(A) (Stratagene, Incorporated, La Jolla, California). RMA.Dd transfeo- 
tants were selected by culture in medium containing 6416 (2 mglml) 
and cloned. After 3 days in culture, transfected RMAIS cells were 
stained with MAb 34-2-12s and positive cells sorted. Sorting was re- 
peated three times and positive cells from the last sorting were cloned 
in the presence of G416. 
Cytolytlc Away 
Target cells were incubated overnight at 37OC or at room temperature 
in the presence or absence of peptides and in the presence of 10% 
FCS. 0.2% FCS, or 0.2% FCS plus h&m, as indicated. Cells were 
labeled with s’Cr for 1 hr or overnight, at 37OC or room temperature, 
as indicated, then washed extensively before the assay. For the ADCC 
reaction, target cells, after 51Cr labeling, were incubated with 10 pg/ 
ml of rat IgGPb anti-mouse Thy-l .2 MAb for 30 min on ice, and then 
washed extensively before the assay. For cytolytic assay, A-LAK cells 
were incubated for 3.6-4.5 hr at 37OC with IO’ labeled target cells as 
previously described (Liao et al., 1991). 
lmmunofluorescent Strlnlng 
Tumor cells were stained directly with fluorescinated antibodies spe 
cific for class I molecules. For analysis, a Coulter Epics XL-MCL (Hia- 
leah, Florida) or a FACScan analyzer (Becton Dickinson, San Jose, 
California) were employed. For sorting, a Coulter Epics Eliie flow cytom- 
eter was employed. Dead cells were excluded on the basis of forward 
and side light scatter. 
Synthetic Peptldes 
pHIV, pTum-, pOVA, and pNP peptides were synthesized at the Micro- 
chemical Facility, Cancer Research Laboratory at University of Califor- 
nia, Berkeley, and desalted using Sep-Pak Cl6 cartridges (Millipore, 
Milford, Massachusetts). Purified pD36. pD36A, pD39, and pD44 pep- 
tides were purchased from Chiron Mimotopes (Emeryville, California). 
All peptides were dissolved in phosphate-buffered saline and quanti- 
tated by the BCA (bicinchoninic acid) protein assay reagent (Pierce, 
Rockford, Illinois). 
Purlflcatlon of Peptides Sound to Class I Molecules 
p-bound peptideswere eluded from affinity-purified Dd molecules from 
RMA.D cells as previously described (Hunt et al., 1992) with modifica- 
tions. Soluble material from cell lysates was loaded onto a series of 
columns of Sepharose 48 beads to which antibodies were directly 
conjugated, in the following order: polyclonal mouse IgG-Sepharose 
48. 28-14-8s-Sepharose 48, 34-2.12s-Sepharose 48 and 34-5-8s- 
Sepharose 48. Columns were separately washed and bound material 
was eluted with 125 mM triethylamine acetate (pl-l 11 .O) and dried in 
a vacuum centrifuge. The eluted material from the latter Iwo (anti-D@) 
columns was pooled. The purified class I molecules were boiled for 
5 min in 10% acetic acid to elute the peptides, which were separated 
from heavy chain and p,m by centrifugation through a filtration device 
(Ultrafree-CL filters, 5,000 NMWL, Millipore. Milford. Massachusetts). 
Material smaller than 5 kDa was dried and resuspended in Hank’s 
balanced 8811 solution (HBSS) for class I reconstitution or in 0.1% 
trifluoroacetic acid for HPLC fractionation. Yields of the peptides were 
estimated from the known quantity of Dd molecules, which was deter- 
mined with the BCA protein assay reagent (Pierce). 
Acid Extraotlon of Cells 
Peptides were acid extracted from cells as previously described 
(Storkus et al., 1993) with minor modifications. In brief, cells were 
harvested and washed twicewith HBSS, then resuspended in acetate- 
phosphate buffer (0.133 M citric acid/O.066 M Na*HPO,) (pH 3.3), at 
1 Ocells/ml, for4 min at room temperature. Peptides in the supernatant 
weredesaltedand concentratedon SepPakC18cartridges(Millipore). 
Cartridges were washed with 15% acetonitrile in HP0 and bound mate- 
rial was eluded with 80% acetonitrile. This material was then dried, 
dissolved in 10% acetic acid, and peptides smaller than 5 kDa isolated 
by fractionation through Ultrafree-CL filters (Millipore). The resulting 
flowthrough was dried and resuspended in HBSS. 
Peptldalnduced Stablllzetlon of Class I Molecules 
on the Cell Surface 
Peptide binding to Dd molecules was assayed by stabilization of Da 
molecules on the cell surface of TAP-deficient RMAISD cells, as 
detected with an anti-w antibody (34-5-8s) specific for B conformation- 
dependent epitope on the alla2 domains. Cells were washed twice 
in the absence of FCS and then resuspended a1 l-l .5 x IO6 cells/ 
ml in 0.2% FCS-RPMI, in the presence or the absence of hg,m as 
indicated. The cells were incubated with graded doses of peptides 
overnight at room temperature or 37OC, washed, and stained for D4 
expression. With HPLC fractions, RMAIS.Ddcellswereincubatedover- 
night at room temperature lo maximize MHC expression at the cell 
surface, then with the HPLC fractions for 4 hr at 37OC before staining. 
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